209 related articles for article (PubMed ID: 33781630)
21. Prenatal RHD genotyping in Croatia: preliminary results.
Bingulac-Popović J; Babić I; Đogić V; Kundid R; Simović Medica J; Mišković B; Jukić I
Transfus Clin Biol; 2021 Feb; 28(1):38-43. PubMed ID: 33227453
[TBL] [Abstract][Full Text] [Related]
22. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive fetal RhCE genotyping from maternal blood.
Geifman-Holtzman O; Grotegut CA; Gaughan JP; Holtzman EJ; Floro C; Hernandez E
BJOG; 2009 Jan; 116(2):144-51. PubMed ID: 18503573
[TBL] [Abstract][Full Text] [Related]
24. Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review.
Runkel B; Bein G; Sieben W; Sow D; Polus S; Fleer D
BMC Pregnancy Childbirth; 2020 Feb; 20(1):83. PubMed ID: 32033599
[TBL] [Abstract][Full Text] [Related]
25. Genotyping approach for non-invasive foetal RHD detection in an admixed population.
Boggione CT; Luján Brajovich ME; Mattaloni SM; Di Mónaco RA; García Borrás SE; Biondi CS; Cotorruelo CM
Blood Transfus; 2017 Jan; 15(1):66-73. PubMed ID: 27136427
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
[TBL] [Abstract][Full Text] [Related]
27. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.
Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V
Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138
[TBL] [Abstract][Full Text] [Related]
28. The use of maternal plasma for prenatal RhD blood group genotyping.
Finning K; Martin P; Daniels G
Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis.
Zhu YJ; Zheng YR; Li L; Zhou H; Liao X; Guo JX; Yi P
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1839-44. PubMed ID: 24422551
[TBL] [Abstract][Full Text] [Related]
30. Implementation of high-throughput non-invasive prenatal testing for fetal RHD genotype testing in England: Results of a cross-sectional survey of maternity units and expert interviews.
Ryczek E; White J; Carolan-Rees G
Transfus Med; 2020 Aug; 30(4):287-294. PubMed ID: 32447792
[TBL] [Abstract][Full Text] [Related]
31. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies.
Freeman K; Szczepura A; Osipenko L
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):91-8. PubMed ID: 19081172
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
Cardo L; García BP; Alvarez FV
Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
[TBL] [Abstract][Full Text] [Related]
35. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive approach for the management of hemolytic disease of the fetus.
Illanes S; Soothill P
Expert Rev Hematol; 2009 Oct; 2(5):577-82. PubMed ID: 21083022
[TBL] [Abstract][Full Text] [Related]
37. Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma.
Dovč-Drnovšek T; Klemenc P; Toplak N; Blejec T; Bricl I; Rožman P
Transfus Med Hemother; 2013 Feb; 40(1):37-43. PubMed ID: 23637648
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population.
Schmidt LC; Cabral AC; Faria MA; Monken F; Tarazona-Santos E; Martins ML
Genet Mol Res; 2014 Feb; 13(1):799-805. PubMed ID: 24615044
[TBL] [Abstract][Full Text] [Related]
39. Fetal blood group genotyping: present and future.
Daniels G; Finning K; Martin P; Summers J
Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
